Showing 31-40 of 108 results for "".

• MATV News: New Restylane Fillers FDA Approved; Hyperhidrosis and Anxiety; Educating Plastic Surgery Patients

  https://modernaesthetics.com/series/matv-news/new-restylane-fillers-fda-approved-hyperhidrosis-and-anxiety-educating-plastic-surgery-patients/33400/
  The FDA approved two new Galderma Restylane fillers for the treatment of nasolabial folds or laugh lines in patients over the age of 21. Patients with hyperhidrosis may be more likely to be anxious or depressed and you may want to council cosmetic surgery patients to stop prior to undergoing procedu
  • Video

• Three Ways: Waste Not, Want Not: Where Do Practices Waste the Most Money?

  https://modernaesthetics.com/ma-issues-index/2018-july-aug/waste-not-want-not-where-do-practices-waste-the-most-money/34096/
  Everyone likes “found money”! Modern Aesthetics® marketing pros share their biggest pet peeves about how aesthetic practices waste money and give tips on ways to boost the bottom line.
  • Text

• Understanding and Treating Estrogen Deficient Skin: A Panel Discussion About an Entirely New Category of Skin Care

  https://modernaesthetics.com/ma-supplements/2019-june-may-supplement/understanding-and-treating-estrogen-deficient-skin-a-panel-discussion-about-an-entirely-new-category-of-skin-care/33964/
  Biopelle, Inc. has launched Emepelle, the first and only clinically proven skin care line that safely and effectively helps address estrogen deficient skin (EDS) with revolutionary, new MEP Technology™. To coincide with the launch, a panel of leading dermatologists convened recently to discuss the p
  • Text

• MATV News: DREAM Initiative’s Forces of Beauty Report; AAFPRS Medical Mission Trip to Ukraine; Galderma’s Investigational Neurotoxin Gets High Marks

  https://modernaesthetics.com/series/matv-news/matv-news-dream-initiatives-forces-of-beauty-report-aafprs-medical-mission-trip-to-ukraine-galdermas-investigational-neurotoxin-gets-high-marks/33706/
  Allergan Aesthetics and skinbetter science have released a new report from their DREAM Initiative. The Forces of Beauty report provides a new understanding of what inclusive and representative beauty looks like today. Plastic surgeon Kelly Bolden, MD discusses the importance of the findings. America
  • Video
• Xeomin Performs Well in Phase 3 Studies of Upper Facial Lines
  https://modernaesthetics.com/news/xeomin-performs-well-in-phase-3-studies-of-upper-facial-lines/2473428/
  Two pivotal phase 3 clinical studies demonstrated the efficacy and safety of Xeomin (incobotulinumtoxinA) in the simultaneous treatment of horizontal forehead lines, glabellar frown lines, and lateral canthal lines, according to Merz Aesthetics. Merz Aesthetics will submit these data as
• Allergan Aesthetics Submits BLA for TrenibotulinumtoxinE for Glabellar Lines
  https://modernaesthetics.com/news/abbvie-submits-bla-for-trenibotulinumtoxine-for-glabellar-lines/2475351/
  Allergan Aesthetics, an AbbVie Company, has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE), seeking approval for the treatment of moderate to severe glabellar lines. TrenibotE, a serotype E botulinum to
• Evolus Acquires Exclusive US Distribution Rights to Evolysse Line of Dermal Fillers
  https://modernaesthetics.com/news/evolus-acquires-exclusive-us-distribution-rights-to-evolysse-line-of-dermal-fillers/2473412/
  Evolus has entered into a definitive agreement to be the exclusive US distributor of a line of five dermal fillers currently in late-stage development. Evolus is partnering with Symatese, a privately held French company, to introduce the Evolysse line to its US customers beginning
• Top-line Phase 3 Data Promising for Galderma's RelabotulinumtoxinA
  https://modernaesthetics.com/news/top-line-phase-3-data-promising-for-galdermas-relabotulinumtoxina/2473250/
  Galderma’s investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves both glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line phase 3 data presen
• FDA Approves South Korean Neurotoxin for Frown Lines
  https://modernaesthetics.com/news/fda-approves-south-korean-neurotoxin-for-frown-lines/2473751/
  The US Food and Drug Administration approved the neurotoxin, Letybo (letibotulinumtoxinA-wlbg), to treat moderate-to-severe glabellar lines in adults, Hugel Inc. announced last week.  According to a press release, Hugel Inc. plans to accelerate its transition for approved medical u
• New Ophthalmologist-Created Eye Skincare Line Launches
  https://modernaesthetics.com/news/new-ophthalmologist-created-eye-skincare-line-launches/2473236/
  Now available for pre-order, Daily Practice, the new eye care line by Ashley Brissette, MD, has launched with a hero product—Eye Revive. Having worked as an ophthalmologist for six years, New York City-based Dr. Brissette says she recognized a grow

• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• …
• 10
• 11
• Next